Metabolon Expands Inflammation Portfolio with Targeted Panels for Cannabinoids, Sphingolipids, and Lipid Mediators of Inflammation read more
Metabolon Advances the Understanding of Inflammation and Inflammatory Response with New Oxysterols Targeted Panel read more
The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites read more
Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease read more
A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism read more
Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling read more
Metabolomic Profiles Associated with BMI, Waist Circumference, and Diabetes and Inflammation Biomarkers in Women read more
NAD+ precursor supplementation prevents mtRNA/RIG-I-dependent inflammation during kidney injury read more
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice read more